REQUEST A DEMO
Total
USD $0.00
Search more companies

Kangmei Pharmaceutical Co.,Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Kangmei Pharmaceutical Co.,Ltd Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

The company is one of earliest Chinese medicine tablet producer to pass GMP certification. It is the largest Chinese medicine tablet producer in China with most complete varieties. The main products are chemical medicine and Chinese medicine tablet. The company owns chemical drugs and Chinese medicine tablet (including toxic tablet) that have already passed the national GMP certification and two modern production bases. Currently the Chinese medicine tablet production base is of the largest, high-end and with most complete products national GMP standard Chinese medicine production model base with capacity of 3,000 tons tables. With the completion of 2nd phase, the production capacity will reach 1.1 million tons. The company has over 7,000 kinds medicine and medical devices that passed national GMP authentication. In addition, the company also holds 10% shares of Guangdong Development Fund.

Headquarters
Kangmei Traditional Chinese Medicine T. Jieshen R. Puning Guangdong
Shenzhen; Guangdong; Postal Code: 518000

Contact Details: Purchase the Kangmei Pharmaceutical Co.,Ltd report to view the information.

Website: http://www.kangmei.com.cn

Basic Information
Total Employees:
Purchase the Kangmei Pharmaceutical Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Kangmei Pharmaceutical Co.,Ltd report to view the information.
Registered Capital:
Purchase the Kangmei Pharmaceutical Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Kangmei Pharmaceutical Co.,Ltd report to view the information.
Incorporation Date:
June 18, 1997
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
25.31%
Purchase this report to view the information.
5.21%
Purchase this report to view the information.
4.71%
Purchase this report to view the information.
2.98%
Purchase this report to view the information.
1.67%
Subsidiaries
Beijing Kangmei Pharmaceutical Co., Ltd.
100%
Beijing Kangmeiyikanglai Pharmaceutical Co., Ltd.
100%
Bozhou Kangmei Chinese Medicinal Plants Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Kangmei Pharmaceutical Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
46.41%
Total operating revenue
45.08%
Operating profit (EBIT)
-52.98%
Net Profit (Loss) for the Period
-17.17%
Total assets
-0.15%
Total equity
-0.35%
Operating Profit Margin (ROS)
-0.22%
Net Profit Margin
1.05%
Return on Equity (ROE)
-0.32%
Debt to Equity Ratio
16.28%
Quick Ratio
-0.03%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?